Alexandria Venture Investments Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 362

  • Portfolio
  • 155

  • Exits
  • 116

Exits

Alexandria Venture Investments General Information

Description

Founded in 1996, Alexandria Venture Investments is the corporate venture capital arm of Alexandria Real Estate Equities based in Pasadena, California. The firm prefers to invest in seed-stage, early-stage, and growth-stage companies operating in the healthcare, disruptive life science, agrifood technology, climate innovation, and information technology sectors.

Contact Information

Year Founded
1996
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
Primary Investor Type
Corporate Venture Capital
Primary Office
  • 26 North Euclid Avenue
  • Pasadena, CA 91101
  • United States
+1 (626) 000-0000

Alexandria Venture Investments Investments (362)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Alto Neuroscience 21-Nov-2023 Later Stage VC 0000 Drug Discovery Generating Revenue
Triveni Bio 26-Oct-2023 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2
DEKA Biosciences 28-Sep-2023 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1
Arialys 12-Sep-2023 0000 00000 0000 Biotechnology Startup
ROME Therapeutics 12-Sep-2023 00000 00000 00000 Drug Discovery Pre-Clinical Trials
Georgiamune 09-Aug-2023 00000 00000 0000 Biotechnology Clinical Trials - General
Neurogene 18-Jul-2023 0000 0000 Drug Discovery Generating Revenue
AltPep 22-Jun-2023 00000 00000 000.00 Drug Discovery Pre-Clinical Trials 0000 000000 00
Bitterroot Bio 07-Jun-2023 Early Stage VC 00000 Drug Discovery Generating Revenue
Mozart Therapeutics 31-May-2023 Early Stage VC 0000 Drug Discovery Generating Revenue
You’re viewing 10 of 362 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alexandria Venture Investments Exits (116)

Company Name Exit Date Exit Type Exit Size
Korro Bio 03-Nov-2023 Reverse Merger
Lexeo Therapeutics 03-Nov-2023 000 00000
Theonys 17-Oct-2023 000 00 00000000
Neumora 15-Sep-2023 000 00000
RayzeBio 15-Sep-2023 000 00000
Nanosys 07-Sep-2023 000000000000000000
DICE Therapeutics 09-Aug-2023 000000000000000000 00.00
Haystack Oncology 20-Jun-2023 000000000000000000 00000
Cibus 01-Jun-2023 Reverse Merger
Cardea 29-Apr-2023 Merger/Acquisition
You’re viewing 10 of 116 exits. Get the full list »

Alexandria Venture Investments Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Alexandria Venture Investments Team (8)

Name Title Deals Funds Boards Office
Jenna Foger Senior Vice President, Science & Technology 0 Pasadena, CA
Aaron Jacobson Senior Vice President, Venture Counsel Pasadena, CA
Jeff Stevens Vice President 0 0 Pasadena, CA
Joel Marcus JD Founder & Executive Chairman of the Board of Directors 00 0 00 Pasadena, CA
You’re viewing 4 of 8 team members. Get the full list »

Alexandria Venture Investments Co-Investors (664)

Name With Exits Lead Partner Series Industry
ARCH Venture Partners 25 0 0 Series chart Industry bar
Casdin Capital 00 0 0 Series chart Industry bar
GV 00 0 0 Series chart Industry bar
The Invus Group 00 0 Series chart Industry bar
RA Capital Management 00 0 0 Series chart Industry bar
You’re viewing 5 of 664 co-investors. Get the full list »